Literature DB >> 2167111

A model for tumor cell killing by topoisomerase poisons.

H Zhang1, P D'Arpa, L F Liu.   

Abstract

Our model proposes that topoisomerase-targeting antitumor drugs form reversible drug-enzyme-DNA complexes that collide with the DNA and RNA synthesis machineries. On collision, the complexes lose their reversibility, and generate lethal double-strand DNA breaks. Further investigations of topoisomerase action will allow this model to be refined, and may ultimately lead to the development of more effective anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167111

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  23 in total

1.  Camptothecin Efficacy to Poison Top1 Is Altered by Bisphenol A in Mouse Embryonic Fibroblasts.

Authors:  Manoj Sonavane; Peter Sykora; Joel F Andrews; Robert W Sobol; Natalie R Gassman
Journal:  Chem Res Toxicol       Date:  2018-06-05       Impact factor: 3.739

2.  VERNONIA AMYGDALINA DELILE EXHIBITS A POTENTIAL FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA.

Authors:  Clement G Yedjou; Jennifer N Sims; Sylvianne Njiki; Nole Tsabang; Ifedayo V Ogungbe; Paul B Tchounwou
Journal:  Glob J Adv Eng Technol Sci       Date:  2018-08-10

3.  Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide.

Authors:  I Gradzka; T Iwaneńko; M Kruszewski; I Szumiel; M Kapiszewska; C S Lange; G Afanasjev
Journal:  Radiat Environ Biophys       Date:  1996-08       Impact factor: 1.925

Review 4.  Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes.

Authors:  N Osheroff; A H Corbett; S H Elsea; M Westergaard
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells.

Authors:  W T Beck; R Kim; M Chen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line.

Authors:  C D Evans; S E Mirski; M K Danks; S P Cole
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.

Authors:  Chao-Po Lin; Yi Ban; Yi Lisa Lyu; Leroy F Liu
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

8.  Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine.

Authors:  C M Chresta; R Hicks; J A Hartley; R L Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Acidic pH induces topoisomerase II-mediated DNA damage.

Authors:  Hai Xiao; Tsai-Kun Li; Jin-Ming Yang; Leroy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

10.  DNA repair functions that control sensitivity to topoisomerase-targeting drugs.

Authors:  Mobeen Malik; John L Nitiss
Journal:  Eukaryot Cell       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.